“…High seroprevalence from 30% to 98%, depending on the geographical area, was reported. Indeed, a number of epidemiological reports concern only the seroprevalence of BDV infection in many countries, such as Austria [ 46 ], Chile [ 107 ], Denmark [ 108 ], Iran [ 109 ], Iraq [ 110 ], Ireland [ 111 , 112 ], Israel [ 3 ], the Netherlands [ 84 ], Peru [ 113 , 114 ], Sweden [ 115 ], Switzerland [ 40 , 96 ], the UK [ 116 ], and Mediterranean countries such as Algeria [ 117 ], Morocco [ 118 ], Tunisia [ 119 ], and Turkey [ 19 , 120 ]. Nevertheless, only a few cases were confirmed by virus isolation or molecular characterization.…”